FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 1,567,916	$ 1,641,139
Gross Unrealized Gains	57	159
Gross Unrealized Losses	(11,238)	(15,926)
Aggregate Fair Value	1,556,735	1,625,372
Cash and Cash Equivalents	694,381	724,531	[1]
Short-term marketable securities	476,577	567,006	[1]
Long-term marketable securities	$ 385,777	$ 333,835	[1]
Maximum
Schedule of Available-for-sale Securities [Line Items]
Short term marketable securities maturity period	1 year	1 year
Long term marketable securities maturity period	5 years	5 years
Minimum
Schedule of Available-for-sale Securities [Line Items]
Long term marketable securities maturity period	1 year	1 year
Level 1: | Cash
Schedule of Available-for-sale Securities [Line Items]
Cash	$ 306,006	$ 463,248
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Aggregate Fair Value	306,006	463,248
Cash and Cash Equivalents	306,006	463,248
Short-term marketable securities	0	0
Long-term marketable securities	0	0
Level 2:
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	1,261,910	1,177,891
Gross Unrealized Gains	57	159
Gross Unrealized Losses	(11,238)	(15,926)
Aggregate Fair Value	1,250,729	1,162,124
Cash and Cash Equivalents	388,375	261,283
Short-term marketable securities	476,577	567,006
Long-term marketable securities	385,777	333,835
Level 2: | Money market instruments
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	382,127	248,933
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Aggregate Fair Value	382,127	248,933
Cash and Cash Equivalents	382,127	248,933
Short-term marketable securities	0	0
Long-term marketable securities	0	0
Level 2: | Corporate debt securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	420,171	504,984
Gross Unrealized Gains	34	34
Gross Unrealized Losses	(7,194)	(11,541)
Aggregate Fair Value	413,011	493,477
Cash and Cash Equivalents	0	1,881
Short-term marketable securities	223,194	299,153
Long-term marketable securities	189,817	192,443
Level 2: | U.S. government agency securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	386,313	312,720
Gross Unrealized Gains	8	45
Gross Unrealized Losses	(3,508)	(3,771)
Aggregate Fair Value	382,813	308,994
Cash and Cash Equivalents	6,248	0
Short-term marketable securities	243,078	229,846
Long-term marketable securities	133,487	79,148
Level 2: | Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	8,929	48,103
Gross Unrealized Gains	2	11
Gross Unrealized Losses	(1)	(22)
Aggregate Fair Value	8,930	48,092
Cash and Cash Equivalents	0	10,469
Short-term marketable securities	8,930	37,623
Long-term marketable securities	0	0
Level 2: | Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	64,370	63,151
Gross Unrealized Gains	13	69
Gross Unrealized Losses	(535)	(592)
Aggregate Fair Value	63,848	62,628
Cash and Cash Equivalents	0	0
Short-term marketable securities	1,375	384
Long-term marketable securities	$ 62,473	$ 62,244

[1] (1)December 31, 2022 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 27, 2023.